- Recent Funding
- Investors
- 3W Partners Capital
3W Partners Capital portfolio
3W Partners Capital has 1 portfolio company on record at Recent Funding.
About this page
Its most recent investment on record is LifeMine Therapeutics's $175M Series B+ round in March 2022, alongside ARCH Venture Partners, Fidelity Management & Research Company, Blue Pool Capital and 4 others. That company is in Health and bio.
What 3W Partners Capital invests in
- Health and bio · 1 · 100%
How 3W Partners Capital invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 1 100% | $175M |
3W Partners Capital portfolio companies
LLifeMine Therapeutics$175MSeries B+ · Mar 2022
| Company | Round with 3W Partners Capital | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $175M | $543M | Aug 6, 2026 Series B+ |
Most frequent co-investors
GGV1 shared round · last Mar 23, 2022
IInvus1 shared round · last Mar 23, 2022
MMRL Ventures Fund1 shared round · last Mar 23, 2022
AARCH Venture Partners1 shared round · last Mar 23, 2022
BBlue Pool Capital1 shared round · last Mar 23, 2022
- FFidelity Management & Research Company1 shared round · last Mar 23, 2022
GGSK1 shared round · last Mar 23, 2022
Similar investors
IIzou Partners2 companies · 2 deals in 12 mo
- TThe Ljungstrom Family Office2 companies · 2 deals in 12 mo
OO'Shaughnessy Ventures3 companies · 1 deal in 12 mo
SSide Stage Ventures3 companies
AAble Partners4 companies · 1 deal in 12 mo
GGenoa Ventures5 companies · 4 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name 3W Partners Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists 3W Partners Capital, which is a subset of its real portfolio. API: /api/v1/investors/3w-partners-capital (get a free API key). More: the most active VC firms and new venture capital funds.